Discover the biosimilars market's expansion to US$171.79 billion by 2033 with 25.5% CAGR. Key insights on North America's leading share, monoclonal antibodies' prominence, and applications in oncology (rising cancer cases to 29.9M by 2040) fueled by major players like copyright and Amgen. https://finance.yahoo.com/news/biosimilars-market-surpass-us-171-141500245.html